A subgroup of NNE patients had low EPO levels equivalent to PV, highlighting the risk of using low levels of EPO as a diagnostic marker for JAK2‐negative PV without a careful bone marrow examination. The gene discussed is JAK2; the disease is acquired polycythemia vera.